fluorescein-5-isothiocyanate and npi 2358

fluorescein-5-isothiocyanate has been researched along with npi 2358 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hayashi, Y; Kiso, Y; Lloyd, GK; Miller, BR; Neuteboom, ST; Nicholson, B; Palladino, MA	1

Other Studies

1 other study(ies) available for fluorescein-5-isothiocyanate and npi 2358

Article	Year
NPI-2358 is a tubulin-depolymerizing agent: in-vitro evidence for activity as a tumor vascular-disrupting agent. Anti-cancer drugs, 2006, Volume: 17, Issue:1 Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Cell Membrane Permeability; Cell Survival; Colchicine; Dextrans; Diketopiperazines; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Endothelial Cells; Endothelium, Vascular; Fluorescein-5-isothiocyanate; HL-60 Cells; HT29 Cells; Humans; Imidazoles; Inhibitory Concentration 50; Jurkat Cells; Microtubules; Neoplasms; Piperazines; Stilbenes; Time Factors; Tubulin; Vincristine	2006

Article

Year

NPI-2358 is a tubulin-depolymerizing agent: in-vitro evidence for activity as a tumor vascular-disrupting agent.

Anti-cancer drugs, 2006, Volume: 17, Issue:1

Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Cell Membrane Permeability; Cell Survival; Colchicine; Dextrans; Diketopiperazines; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Endothelial Cells; Endothelium, Vascular; Fluorescein-5-isothiocyanate; HL-60 Cells; HT29 Cells; Humans; Imidazoles; Inhibitory Concentration 50; Jurkat Cells; Microtubules; Neoplasms; Piperazines; Stilbenes; Time Factors; Tubulin; Vincristine

2006